国际医药商学院2023年度“圣和研究生创新成果奖” 获选名单公示

根据研究生院《关于开展2023年度“圣和研究生创新成果奖”评选工作的通知》规定，经个人申报、学院审核及专家评审等程序，评定何思瑜等8名同学获得国际医药商学院2023年度“圣和研究生创新成果奖”，现将获奖名单予以公示。公示时间自2023年11月15日至20日，公示期内对获选名单有异议者，可向学院书面提出意见。联系人：刘老师，联系电话：86185036。

中国药科大学国际医药商学院

2023年11月15日

序号	姓名	学号	学科专业	发表论文题目	发表期刊	获奖等级	奖金金额
1	何思瑜	3320041598	管理药学	Psychometric Comparison of EQ-5D-Y, CHU-9D, and PedsQL 4.0 in Chinese Children and Adolescents With Functional Dyspepsia: A Multicenter Study	value in health	二等奖	2000
2	谷阳	3222041131	社会与管理药学	Does China’s centralize volume-based drug procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference model	Frontiers in Pharmacology	三等奖	1000
3	邵泰航	3221041150	药物经济学	Serplulimab plus chemotherapy vs chemotherapy for treatment of US and Chinese patients with extensive-stage small-cell lung cancer: a cost-effectiveness analysis to inform drug pricing	BioDrugs	三等奖	1000
4	代展菁	3121040194	药物经济学	Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer Treatment	PHARMACOECONOMICS	三等奖	1000
5	陈亮江	3320041593	管理药学	Development and validation of pharmaceutical care barriers scale in Chinese hospitals: a cross-sectional survey	Frontiers in Pharmacology	三等奖	1000
6	梁乐怡	3321041252	管理药学	Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China	BMC Public health	三等奖	1000
7	那昕	3221041125	社会与管理药学	Effects of Basic Medical Insurance Consolidation on Subjective Well-being of Residents in China: Empirical Evidence from a Quasi-experiment	Frontiers in Public Health	三等奖	1000
8	蒙文鑫	3322041279	管理药学	Female perspective: the burden of Alzheimer's disease and other dementias in China from 1990 to 2019 and prediction of their prevalence up to 2044	Frontiers in Public Health	三等奖	1000